Study details
Enrolling now
Prevention of Postoperative Atrial Fibrillation Using Intra-Pericardial Amiodarone
University of Chicago
NCT IDNCT06063538ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
63
Study length
about 3.4 years
Ages
20–85
Locations
1 site in IL
What this study is about
Researchers are testing a treatment to prevent atrial fibrillation after surgery. The treatment involves CardiaMend combined with amiodarone, given directly around the heart. The trial will last for 1231 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take CardiaMend in Combination with Amiodarone
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
amiodarone
Body systems
Cardiology / Heart